Atezolizumab Monotherapy as First-line Treatment in Patients with Advanced BRAFV600 Wild-type Melanoma

Autor:	Rodrigo R. Pereira, Pedro E.R. Liedke, Sergio J Azevedo, Andrea B. Zanon, Taiane F Rebelatto, Juliano Ce Coelho
Rok vydání:	2021
Předmět:	First line treatment Oncology medicine.medical_specialty Atezolizumab business.industry Internal medicine Melanoma Wild type medicine In patient medicine.disease business
Zdroj:	Journal of Clinical Haematology. 2
DOI:	10.33696/haematology.2.034
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2d3a9590d1c3337af53996162f53ded3 https://doi.org/10.33696/haematology.2.034 Zobrazit plný text záznamu